未登录

M

Maike Zimmermann

University of California System

H指数:13

被引数:644

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dual COX-2/sEH Inhibition and Immune Checkpoint Blockade Regress Bladder Cancer Tumors in Mice

IF4.2

2022-05-130

PRE

Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy

MOLECULAR CANCER THERAPEUTICS

IF5.5

2020-04-0219

OAAI

Microdose induced oxaliplatin-DNA adducts as a predictive biomarker of response in colorectal cancer

CANCER RESEARCH

IF16.6

2019-07-010

PRE

A patient-derived xenograft (PDX) platform for cancer translational, precision medicine and health disparity research

CANCER RESEARCH

IF16.6

2019-07-010

OA

Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science

IF4.1

2019-05-099

OAAI

Correlation of Platinum Cytotoxicity to Drug-DNA Adduct Levels in a Breast Cancer Cell Line Panel

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2018-11-0114

OAAI

COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-02-0136

OAAI

A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-05-1514

OAAI

Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice

MOLECULAR CANCER THERAPEUTICS

IF5.5

2017-02-0223

OAAI

DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2017-01-0355

OAAI

Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival

IF3.4

2016-11-0837

OAAI

Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2016-10-1113

OAAI

Diagnostic Microdosing Approach to Study Gemcitabine Resistance

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2016-10-108

OAAI

Dual-label microdosing approach to identify chemoresistance to carboplatin and gemcitabine combination chemotherapy

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Molecular dissection of platinum resistance through functional analysis

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis

BIOCHEMICAL JOURNAL

IF4.3

2013-12-1015

PREAI

Elevated Cyclin G2 Expression Intersects with DNA Damage Checkpoint Signaling and Is Required for a Potent G2/M Checkpoint Arrest Response to Doxorubicin

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2012-06-0148

OAAI

mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells

mTOR支持人类胚胎干细胞的长期自我更新并抑制中胚层和内胚层的活动

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2009-05-12200

OAAI